ALLIANÇA SAÚDE E PARTICIPAÇÕES S.A. (“Company” or “Alliança”) , in compliance with the provisions of CVM Resolution No. 44/2021 and CVM Resolution No. 133/2022 and in addition to the Notice to the Market published on September 6, 2023 , informs its shareholders and the market in general that it has concluded negotiations with UNIMED NACIONAL – COOPERATIVA CENTRAL (“Unimed Nacional”) , as well as signed, on this date, an Investment Agreement and Other Covenants (“Agreement”) for the creation of laboratories for the processing of clinical analysis exams, known in the health segment as Núcleo Técnico Operacional (“NTO”) in the State of Bahia , more specifically in the following cities Camaçari, Candeias, Dias D’Avila, Lauro de Freitas, Salvador, and Simões Filho.
The execution of the Agreement with Unimed Nacional is in line with the Company’s strategic plan and will increase the volume of revenue from clinical analysis exams carried out at Alliança , as well as increase the capillarity of Delfin brand collection points, located in the Northeast region of the country.
The Agreement also provides for the transformation of a limited liability company to a joint stock company of one of Alliança’s subsidiary , provisionally named Rifeu Participações e Investimentos Ltda. (“Vehicle”) , which will have its share capital formed exclusively by common shares and a 49% stake in the voting share capital held by Unimed Nacional.
The Vehicle will be a holding company holding investments in subsidiaries created with the specific purpose of creating and operating NTOs, initially located in the Northeast region of the country.
Among the conditions precedent, the Parties must have:
-
(a) completed the negotiation of documents ancillary to the Agreement, such as a cost and expense sharing agreement related to the Vehicle’s backoffice structure;
-
(b) formalization of the service provision contract and NTO accreditation; and
-
(c) obtained authorization from CADE and other applicable government authorizations to conclude the operations.
Alliança will keep its shareholders and the market informed about the facts related to this project.
São Paulo, 24 de janeiro de 2024
ALLIANÇA SAÚDE E PARTICIPAÇÕES S.A.